A multicenter phase II trial of decitabine as first-line treatment for older patients with acute myeloid leukemia judged unfit for induction chemotherapy
Lubbert, M., Ruter, B. H., Claus, R., Schmoor, C., Schmid, M., Germing, U., Kuendgen, A., Rethwisch, V., Ganser, A., Platzbecker, U., Galm, O., Brugger, W., Heil, G., Hackanson, B., Deschler, B., DohnVolume:
97
Language:
english
Journal:
Haematologica
DOI:
10.3324/haematol.2011.048231
Date:
March, 2012
File:
PDF, 1.01 MB
english, 2012